imaging inflammation in atherosclerotic plaques: just make it easy!

The presence of inflammatory cells is a hallmark of unstable atherosclerotic plaques. several imaging approaches have been developed for the noninvasive detection of inflammatory activities in atherosclerotic plaques. positron emission tomography (pet) imaging with the injection of 18f-fluorodeoxyglucose (fdg) is currently the most widely used imaging technique to evaluate the density of activated macrophages in atherosclerotic plaques. nevertheless, fdg-pet imaging has logistical and technical constraints that represent an important obstacle to the wider use of this approach for the evaluation of patients with atherosclerosis. in a similar way as in the oncological field, the balance between the benefits and costs of new drugs need to be improved in patients with cardiovascular diseases. pet imaging of plaque inflammation might represent a very useful tool to identify patients who could benefit the most from anti-inflammatory treatments and to exclude patients with other causes of inflammation who are the most likely to develop severe side effects under these drugs. the availability of radiotracers targeting more specifically inflammation in atherosclerotic plaques would greatly facilitate the logistic organization of this imaging and help to expand the use of pet for the evaluation of atherosclerotic patients.